A mid-cap Pharma stock projected as a potential 100-bagger by the wizards at Motilal Oswal has already filled the coffers of its shareholders with gold. It is claimed that the stock has more potential for gains because it is now at a “game changer” and “strategic inflection point”
Manish Bhandari’s PMS has reported a spectacular performance with some stocks blowing off the ceiling with up to 11x gains in just 18 months. He has also announced the addition of new stocks to the portfolio, which we have to keep an eagle eye on
Saurabh Mukherjea, the whiz-kid from Ambit, is proving to be a tough nut to crack. Despite the general mood of optimism in the economy, he stays adamantly bearish. He has warned that several aspects of the Indian economy are “misfiring” and that one good monsoon will not turn around the Country’s fortunes
A research analyst who sought to make quick money by taking advantage of insider information is in serious trouble. His attempt to avoid detection of his insider trades by using his mother’s account has come a cropper. He has now not only to refund his ill-gotten gains but also faces serious criminal charges
Dolly Khanna appears to have overcome her aversion to Pharma stocks. This time, instead of being a lone wolf, she has relied on the collective wisdom of Kishore Bang and Motilal Oswal to home in on a micro-cap Pharma stock with impressive past performance and ambitious future plans
Eminent experts have expressed the unanimous view that a mid-cap housing finance stock backed by Rakesh Jhunjhunwala has huge potential and deserves to be bought
Kalpraj Dharamshi is a strong believer in the theory that we must never stop looking for multibagger stocks. He has confidently asserted that there are at least “100 Ten-Baggers And Ten 100-Baggers” stocks waiting to be discovered. One of his favourite “game changer” stocks is such a 10-bagger claims Aashish Tater
A mid-cap Pharma stock strongly recommended by Sanjoy Bhattacharyya & Saurabh Mukherjea is facing the ignominy of being declared a flop. Luckily, another “100 Bagger” Pharma stock is surging and bringing cheer to investors
Porinju Veliyath has issued the clarion call that investors practicing the hallowed art of “value investing” have to also embrace the modern concept of “value trading” if they want to take advantage of irrational pricing of stocks and pocket mega bucks
Rahul Arora of Nirmal Bang has put the spotlight on a top-quality stock backed by visionaries like Billionaire Narayana Murthy & Sanjoy Bhattacharyya. The stock enjoys the unique combination of having high RoE, being debt-free and also offers a high dividend yield
Recent Comments